Short Description

Prostate health index (phi) combines three PSA forms (total PSA, free PSA, and p2PSA) into a single score. p2PSA test measures the [-2]proPSA concentration in serum , [-2]proPSA is one of the isoform of free PSA and has been determined to be most specific to Prostate cancer. phi demonstrates a significant improvement in clinical specificity for prostate cancer detection, relative to PSA alone in men 50 years of age or older with a PSA range of 2-10 ng/mL and with non-suspicious digital rectal exam (DRE) findings. At 95% clinical sensitivity, the clinical specificity for phi is 18.2% as compared to 6.6% for percentage free PSA in diagnostic grey zone. A low phi result indicates lower risk of Prostate cancer, while an elevated phi result may suggest that a prostate biopsy is necessary to rule out the cancer.

PreTest Information

Do not give sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography.

Detail Description

Prostate Health Index (PHI) Test Cost INR:4500 Symptoms Diagnosis

Prostate Health Index (PHI) is a blood test that measures the level of prostate-specific antigen (PSA) and other prostate-related proteins to determine the risk of prostate cancer. This test is highly recommended for men over 50 years of age or those with a family history of prostate cancer.

Symptoms of Prostate Cancer

Prostate cancer often does not show any symptoms in its early stages. However, as the cancer progresses, the following symptoms may occur:

• Frequent urination, especially at night
• Difficulty urinating
• Blood in urine or semen
• Pain or discomfort during ejaculation
• Pain or discomfort in the lower back, hips, or thighs

Diagnosis of Prostate Cancer

Prostate cancer is diagnosed through a combination of tests, including:

• Physical exam
• PSA blood test
• Digital rectal exam
• Prostate biopsy

Prostate Health Index (PHI) Test Cost INR:4500

The cost of the Prostate Health Index (PHI) test in India is INR 4500. The test is available at DNA Labs India, a leading diagnostic center that offers a wide range of tests for various health conditions.

Why Choose DNA Labs India?

• Accurate and reliable test results
• State-of-the-art technology
• Experienced and qualified staff
• Affordable prices
• Quick turnaround time

At DNA Labs India, we understand the importance of early detection and timely treatment of prostate cancer. Our Prostate Health Index (PHI) test is a non-invasive and painless way to assess your risk of prostate cancer. Contact us today to schedule your test and take the first step towards a healthy prostate.

Prostate health index (phi) combines three PSA forms (total PSA, free PSA, and p2PSA) into a single score. p2PSA test measures the [-2]proPSA concentration in serum , [-2]proPSA is one of the isoform of free PSA and has been determined to be most specific to Prostate cancer. phi demonstrates a significant improvement in clinical specificity for prostate cancer detection, relative to PSA alone in men 50 years of age or older with a PSA range of 2-10 ng/mL and with non-suspicious digital rectal exam (DRE) findings. At 95% clinical sensitivity, the clinical specificity for phi is 18.2% as compared to 6.6% for percentage free PSA in diagnostic grey zone. A low phi result indicates lower risk of Prostate cancer, while an elevated phi result may suggest that a prostate biopsy is necessary to rule out the cancer.